BackBioVaxys Technology Overview

BioVaxys Technology Current Cash

Latest current cash for BVAXF: $4.1K.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$4080.00
↓ 99.17% YoYΔ $-486765.00 vs prior year quarter

Peer trimmed avg / median

Loading

BioVaxys Technology Current Cash History

Loading

BioVaxys Technology vs. peers: Current Cash Comparison

Loading

BioVaxys Technology Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

BioVaxys Technology (BVAXF) FAQ

As of the most recent data (July 2025), BVAXF shows a current cash of $4.1K. That compares with $490K in the prior-year period — down 99.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BVAXF's current cash is now $4.1K (was $490K) — a 99.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether BioVaxys Technology is outperforming or lagging.

Tracking BVAXF's current cash over time shows whether BioVaxys Technology is scaling, shrinking, or reshaping that part of the business. The current reading is $4.1K That compares with $490K in the prior-year period — down 99.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has BioVaxys Technology's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $4.1K) with ownership activity and broader fundamentals.

BioVaxys Technology's current cash is $4.1K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.